Could blockchain be the answer to fraud?

Reports of a Chinese vaccine manufacturer fabricating data about its rabies vaccine data has caused an uproar both in China and internationally. It also has also led many to consider blockchain as a potential answer to fraudulent activity. 

Supporters of blockchain use are pushing for adoption in the pharmaceutical industry as a way to ensure every step of a drug’s production and distribution is tracked on a tamper-proof ledger.

Some say vaccine distribution and production is a “public affair” in China, and the vaccine supply chain should be open for all to see. Every detail, from production to the delivery to the end user, in their opinion, should be part of the ledger.

To read the entire story, follow the link below:

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.